Molecular elucidation of receptor-operated Ca^<2+> permeable cation channels with TRP as candidate proteins

以 TRP 作为候选蛋白对受体操纵的 Ca^2 > 渗透性阳离子通道进行分子阐明

基本信息

  • 批准号:
    12670088
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

Stimulation of G-protein coupled or tyrosine kinase receptors often leads to activation of Ca2+-permeable cation channels (ROCCs) which seem to participate in a wide variety of living cells by evoking Ca2+ entry from the extracellular space in direct and indirect ways. Although the molecular identification of ROCCs remains entirely elusive, recent progress in understanding the Drosophila's visual signal transduction has revealed that the vertebrate homologues of transient receptor potential protein (TRPs) are promising candidates for these channels. Based on this knowledge, we have launched on correlating native ROCCs with distinct TRP isoforms at molecular level using the following approach; (1) detailed comparison of cation currents due to native ROCCs and recombinantly expressed TRPs in HEK293 cells with electrophysiological and Ca2+ imaging techniques; (2) detection of TRP mRNAs by RT-PCR and in situ hybridization techniques with TRP isoform specific probes; (3) effects of TRP isof … More orm specific antisense oligonucleotides on native ROCCs. As the results of these studies, we have found that TRP6 is likely to be the essential component of alpha-1 adrenoceptor-activated ROCCs which seem to serve as a membrane depolarizer activating voltage-dependent Ca2+ entry as well as a direct Ca2+ entry pathway that is activated in a store depletion-independent fashion. Thus, TRP6 could be an interesting molecular target of development of anti-hypertensive drugs having entirely new mechanisms (Circ Res. 88, 325-332, 2001). We have also obtained the evidence supporting that TRP6, together with its relative protein, LTRPC2, may form a heretrooligomeric complex which reproduces a number of hallmarks of muscarinic ROCCs widely distributed in the whole gut, some part of brain and adrenal chromaffin cells. In this heterooligomeric configuration, it appears that the signal transduction pathway involved switches from pertussiss toxin-insensitive to sensitive pathways. Such heteromultimeric association of different isoforms of TRP and TRP-related proteins might be responsible for enormous biodiversity of Ca2+ entry associated with cell receptor stimulation. Less
刺激G蛋白偶联或酪氨酸激酶受体通常会导致Ca2+可渗透阳离子通道(ROCC)的激活,这些通道(ROCC)似乎通过以直接和间接方式从细胞外空间中唤起Ca2+进入各种活细胞。尽管ROCC的分子鉴定仍然完全难以捉摸,但在理解果蝇的视觉信号转导方面的最新进展表明,瞬时受体势蛋白(TRP)的脊椎动物同源物(TRP)是这些通道的候选者。基于这些知识,我们使用以下方法在分子水平上纠正具有不同TRP同工型的天然ROCC。 (1)通过电生理和Ca2+成像技术在HEK293细胞中详细比较阳离子电流以及在HEK293细胞中重组表达的TRP; (2)通过RT-PCR检测TRP mRNA和与TRP同工型特异性问题的原位杂交技术; (3)TRP ISOF…更多或特定的反义寡核苷酸对天然ROCC的影响。作为这些研究的结果,我们发现TRP6可能是Alpha-1 adrenoceptor激活的ROCC的重要组成部分,该ROCC似乎是一种膜去极化器激活电压依赖性CA2+进入以及直接的CA2+ CA2+进入途径,该途径在商店deppletion depletion-Intpertentententententententententententententententententent中被激活。这就是TRP6可能是具有全新机制的抗高血压药物发展的有趣分子靶标(Circ Res。88,325-332,2001)。我们还获得了支持TRP6及其相对蛋白LTRPC2的证据,可能会形成一种地球根源络合物,该复合体复制了整个肠道中广泛分布在整个肠道中的毒桃体ROCC的许多标志,这是脑和肾上腺脂肪蛋白细胞的某些部分。在这种杂气组合构型中,看来信号转导途径涉及从对毒素不敏感的敏感途径的开关。 TRP和与TRP相关的蛋白质不同同工型的异植物缔合可能负责与细胞受体刺激相关的Ca2+进入的巨大生物多样性。较少的

项目成果

期刊论文数量(27)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Morita, H., Sharada, T., Takewaki, T., Ito, Y., Inoue, R.: "Multiple regulation by external ATP of nifedipine-insensitive, high voltage-activated Ca2+ current in guinea-pig mesenteric terminal arteriole via two distinct G-protein/protein kinase pathways a
Morita, H.、Sharada, T.、Takewaki, T.、Ito, Y.、Inoue, R.:“通过外部 ATP 对豚鼠肠系膜终末小动脉中硝苯地平不敏感、高电压激活的 Ca2 电流进行多重调节
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Okada T., Inoue R., Yamazaki K., Maeda A., Kurosaki T., Yamakuni T., Tanaka I., Simizu S., Ikenaka K., Imoto K., Mori Y: "Molecular and functional characterization of a novel mouse transient receptor potential protein homologue TRP7: Ca2+ permeable cation
Okada T.、Inoue R.、Yamazaki K.、Maeda A.、Kurosaki T.、Yamakuni T.、Tanaka I.、Simizu S.、Ikenaka K.、Imoto K.、Mori Y:“a 的分子和功能表征
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
井上隆司: "新しい標的分子としてのTRP関連蛋白質受容体作動性陽イオンチャネルとの分子的相関"蛋白質 核酸 酵素. 45(6). 1038-1046 (2000)
Takashi Inoue:“TRP 相关蛋白受体门控阳离子通道作为新靶分子之间的分子相关性”蛋白质核酸酶 45(6) 1038-1046 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Inoue R, Okada T, Onoue H, Hara Y, Shimizu S, Naitoh S., Ito Y, Mori Y: "TRP6 is the essential component of vascular alpha1-adrenoceptor activated Ca2+-permeable cation channel"Circulation Research. 88. 325-332 (2001)
Inoue R、Okada T、Onoue H、Hara Y、Shimizu S、Naitoh S.、Ito Y、Mori Y:“TRP6 是血管 α1-肾上腺素受体激活的 Ca2 渗透性阳离子通道的重要组成部分”循环研究。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
森泰生, 井本敬二, 井上隆司: "カルシウムチャネルの構造と機能"Clinical Calcium. 11(11). 1-8 (2001)
Yasuo Mori、Keiji Imoto、Takashi Inoue:“钙通道的结构和功能”临床钙 11(11)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

INOUE Ryuji其他文献

INOUE Ryuji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('INOUE Ryuji', 18)}}的其他基金

On the mechanism of modal regulation of cardiovascular Ca2+entry channel TRPC6
心血管Ca2+进入通道TRPC6的模态调节机制研究
  • 批准号:
    21590246
  • 财政年份:
    2009
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular elucidation of CaMKII-mediated regulation of vascular receptor-operated Ca^<2+> entry channel TRPC6.
CaMKII介导的血管受体操纵的Ca ^ 2 进入通道TRPC6调节的分子阐明。
  • 批准号:
    17590221
  • 财政年份:
    2005
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of TRPC6 channel specific inhibitor as a new prototypic anti-hypertensive drug.
开发 TRPC6 通道特异性抑制剂作为新的原型抗高血压药物。
  • 批准号:
    14570079
  • 财政年份:
    2002
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation on regulatory mechanisms for smooth muscle receptor-operated Ca^<2+> permeable cation channels using lipid bilayer incorporation of plasma membrane vesicles.
使用质膜囊泡的脂质双层掺入研究平滑肌受体操作的Ca^2可渗透阳离子通道的调节机制。
  • 批准号:
    10670086
  • 财政年份:
    1998
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Multilateral evaluation of abnormal tongue movement combined of ultrasound, EMG and jaw movement analysis
结合超声、肌电图和颌运动分析的舌运动异常的多边评估
  • 批准号:
    09672110
  • 财政年份:
    1997
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Construction of Hybrid Leadership Model Based on Transformational Leadership.
基于变革型领导的混合型领导模型构建。
  • 批准号:
    06451027
  • 财政年份:
    1994
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了